A new study published in the Journal of Clinical Endocrinology & Metabolism suggests that moderate coffee and caffeine consumption may help protect against developing multiple cardiometabolic diseases, such as type 2 diabetes and coronary heart disease.
Researchers found that individuals who regularly consumed moderate amounts of coffee or caffeine had a reduced risk of new-onset cardiometabolic multimorbidity (CM), a condition where a person develops two or more cardiometabolic diseases. “Consuming three cups of coffee, or 200 to 300 milligrams of caffeine per day, might reduce the risk of developing CM in those who have no preexisting cardiometabolic conditions,” said Dr. Chaofu Ke, lead author of the study and researcher from Suzhou Medical College of Soochow University in China.
The study revealed that people consuming around 200 to 300 milligrams of caffeine daily had up to a 48.1% lower risk of developing CM compared to those consuming less than 100 milligrams. The research analyzed data from 172,315 individuals for caffeine consumption and 188,091 individuals for coffee and tea intake.
The findings indicated that moderate coffee and caffeine consumption was inversely associated with the risk of developing CM at all stages. Those who consumed moderate amounts of coffee had the lowest risk of CM, underscoring the potential benefits of incorporating moderate caffeine intake into daily habits for disease prevention.
Previous research has shown that having a single cardiometabolic disease can double the risk of all-cause mortality. In this study, those with CM faced a significantly higher risk of death and additional health complications, including reduced physical function and increased mental stress.
Dr. Ke emphasized the importance of these findings, noting that promoting moderate coffee or caffeine consumption could have “far-reaching benefits for preventing cardiometabolic multimorbidity.”